Sign in

CIK 0001710072

  • Large accelerated filer

Edgewise Therapeutics, Inc.

Sign in to watch
Ticker
EWTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
821725586
Phone
+1 720-262-7002
Business address
1715 38TH ST, BOULDER, CO, 80301
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$201,787
in 1 filing

Net −$201,787. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Nofi Michael −$202K Chief Financial Officer sold 41% of stake
Date Insider Transaction Shares Price Value Owned after
2025-08-12 Carruthers R Michael Chief Financial Officer Exercise or conversion +5,781 87,590
2025-08-12 Carruthers R Michael Chief Financial Officer Sale −1,428 $13.39 $19K 86,162
2025-08-12 Carruthers R Michael Chief Financial Officer Exercise or conversion · Restricted Stock Units −5,781 17,344
2025-08-12 Carruthers R Michael Chief Financial Officer Grant or award · Restricted Stock Units +26,875 26,875
2025-08-12 Carruthers R Michael Chief Financial Officer Grant or award · Stock Option (Right to Buy) +161,250 161,250
2025-05-02 Carruthers R Michael Chief Financial Officer Sale −1,314 $16.45 $22K 81,014
2025-05-01 Carruthers R Michael Chief Financial Officer Exercise or conversion +5,209 82,328
2025-05-01 Carruthers R Michael Chief Financial Officer Exercise or conversion · Restricted Stock Units −5,209 0
2024-10-11 Carruthers R Michael Chief Financial Officer Exercise or conversion +70,000 $0.71 $50K 76,904
2024-10-11 Carruthers R Michael Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −70,000 127,122
2024-09-20 Carruthers R Michael Chief Financial Officer Exercise or conversion +46,068 $1.93 $89K 81,996
2024-09-20 Carruthers R Michael Chief Financial Officer Sale −46,068 $28.59 $1.3M 35,928
2024-09-20 Carruthers R Michael Chief Financial Officer Sale −4,064 $28.59 $116K 31,864
2024-09-20 Carruthers R Michael Chief Financial Officer Sale −24,960 $28.59 $714K 6,904
2024-09-20 Carruthers R Michael Chief Financial Officer Exercise or conversion +50,000 $1.93 $97K 56,904
2024-09-20 Carruthers R Michael Chief Financial Officer Sale −50,000 $28.55 $1.4M 6,904
2024-09-20 Carruthers R Michael Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −96,068 40,990
2024-08-12 Carruthers R Michael Chief Financial Officer Grant or award · Stock Option (Right to Buy) +138,750 138,750
2024-08-12 Carruthers R Michael Chief Financial Officer Grant or award · Restricted Stock Units +23,125 23,125
2024-05-02 Carruthers R Michael Chief Financial Officer Sale −2,157 $18.91 $41K 35,230

Page 1 of 2 · 36 trades